• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Evol . Replacement of the Gamma by the Delta variant in Brazil: Impact of lineage displacement on the ongoing pandemic

tetano

Editor, Senior Moderator
Virus Evol


. 2022 Mar 18;8(1):veac024.
doi: 10.1093/ve/veac024. eCollection 2022.
Replacement of the Gamma by the Delta variant in Brazil: Impact of lineage displacement on the ongoing pandemic


Marta Giovanetti, Vagner Fonseca[SUP] 1 [/SUP], Eduan Wilkinson[SUP] 2 [/SUP], Houriiyah Tegally[SUP] 2 [/SUP], Emmanuel James San[SUP] 2 [/SUP], Christian L Althaus[SUP] 3 [/SUP], Joilson Xavier[SUP] 1 [/SUP], Svetoslav Nanev Slavov[SUP] 4 [/SUP], Vincent Louis Viala[SUP] 5 [/SUP], Alex Ranieri Jerônimo Lima[SUP] 5 [/SUP], Gabriela Ribeiro[SUP] 5 [/SUP], Jayme A Souza-Neto[SUP] 6 [/SUP], Heidge Fukumasu[SUP] 7 [/SUP], Luiz Lehmann Coutinho[SUP] 8 [/SUP], Rivaldo Venancio da Cunha[SUP] 9 [/SUP], Carla Freitas[SUP] 10 [/SUP], Carlos F Campelo de A E Melo[SUP] 11 [/SUP], Wildo Navegantes de Araújo[SUP] 11 [/SUP], Rodrigo Fabiano Do Carmo Said[SUP] 11 [/SUP], Maria Almiron[SUP] 11 [/SUP], Tulio de Oliveira[SUP] 2 [/SUP], Sandra Coccuzzo Sampaio[SUP] 5 [/SUP], Maria Carolina Elias[SUP] 12 [/SUP], Dimas Tadeu Covas[SUP] 4 [/SUP], Edward C Holmes[SUP] 13 [/SUP], José Lourenço[SUP] 12 [/SUP], Simone Kashima[SUP] 4 [/SUP], Luiz Carlos Junior de Alcantara[SUP] 14 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) epidemic in Brazil was driven mainly by the spread of Gamma (P.1), a locally emerged variant of concern (VOC) that was first detected in early January 2021. This variant was estimated to be responsible for more than 96 per cent of cases reported between January and June 2021, being associated with increased transmissibility and disease severity, a reduction in neutralization antibodies and effectiveness of treatments or vaccines, and diagnostic detection failure. Here we show that, following several importations predominantly from the USA, the Delta variant rapidly replaced Gamma after July 2021. However, in contrast to what was seen in other countries, the rapid spread of Delta did not lead to a large increase in the number of cases and deaths reported in Brazil. We suggest that this was likely due to the relatively successful early vaccination campaign coupled with natural immunity acquired following prior infection with Gamma. Our data reinforce reports of the increased transmissibility of the Delta variant and, considering the increasing concern due to the recently identified Omicron variant, argues for the necessity to strengthen genomic monitoring on a national level to quickly detect the emergence and spread of other VOCs that might threaten global health.

Keywords: Brazil; Delta; Gamma; Genomic monitoring; variants replacment.
 
Back
Top Bottom